cmAngio® vs TeraRecon Aorta.CT
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
cmAngio® focuses on detecting breast arterial calcifications on mammograms for early cardiovascular risk assessment, primarily within women's health. TeraRecon Aorta.CT, however, specializes in the automatic segmentation and labeling of the aorta from CT angiography scans to assist in patient management and procedure planning for aortic conditions. While both are AI tools in cardiology, they address distinct anatomical areas and clinical applications with different imaging modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
cmAngiou00ae by CureMetrix is FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment, primarily for women. TeraRecon Aorta.CT is an FDA-cleared AI-powered Software as a Medical Device (SaMD) that automatically segments and labels anatomical landmarks of the Aorta from CT Angiography scans, aiding in patient management and procedure planning for a broader patient population.
cmAngiou00ae processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams. TeraRecon Aorta.CT processes CT Angiography with contrast DICOM images.
cmAngiou00ae provides visualization of BAC location on a scorecard and enables BAC identification and reporting without additional radiation or procedures, compatible with any DICOM-compliant viewer. TeraRecon Aorta.CT outputs DICOM result files for other DICOM-compliant systems, including automatic 3D segmentation and labeling of anatomical landmarks, and integrates with TeraRecon Intuition and Eureka Clinical AI.
cmAngiou00ae offers an adjustable operating point to meet clinical goals and enables BAC identification and reporting without additional radiation or procedures. TeraRecon Aorta.CT aids in patient management and procedure planning by providing automatic segmentation and labeling, but explicitly states it does not alter original input data or provide a diagnosis.